Robert J Harris1,2,3, Jingwen Yao1,2,4, Ararat Chakhoyan1,2, Catalina Raymond1,2, Kevin Leu1,2,3, Linda M Liau5,6, Phioanh L Nghiemphu7, Albert Lai7,5, Noriko Salamon2, Whitney B Pope2, Timothy F Cloughesy7, Benjamin M Ellingson1,2,3,4,8,5. 1. UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 2. Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 3. Physics and Biology in Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 4. Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California Los Angeles, Los Angeles, California. 5. UCLA Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 6. Department of Neurosurgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 7. Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 8. Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Abstract
PURPOSE: To introduce a new pH-sensitive and oxygen-sensitive MRI technique using amine proton CEST echo spin-and-gradient echo (SAGE) EPI (CEST-SAGE-EPI). METHODS: pH-weighting was obtained using CEST estimations of magnetization transfer ratio asymmetry (MTRasym ) at 3 ppm, and oxygen-weighting was obtained using R2' measurements. Glutamine concentration, pH, and relaxation rates were varied in phantoms to validate simulations and estimate relaxation rates. The values of MTRasym and R2' in normal-appearing white matter, T2 hyperintensity, contrast enhancement, and macroscopic necrosis were measured in 47 gliomas. RESULTS: Simulation and phantom results confirmed an increase in MTRasym with decreasing pH. The CEST-SAGE-EPI estimates of R2 , R2*, and R2' varied linearly with gadolinium diethylenetriamine penta-acetic acid concentration (R2 = 6.2 mM-1 ·sec-1 and R2* = 6.9 mM-1 ·sec-1 ). The CEST-SAGE-EPI and Carr-Purcell-Meiboom-Gill estimates of R2 (R2 = 0.9943) and multi-echo gradient-echo estimates of R2* (R2 = 0.9727) were highly correlated. T2 lesions had lower R2' and higher MTRasym compared with normal-appearing white matter, suggesting lower hypoxia and high acidity, whereas contrast-enhancement tumor regions had elevated R2' and MTRasym , indicating high hypoxia and acidity. CONCLUSION: The CEST-SAGE-EPI technique provides simultaneous pH-sensitive and oxygen-sensitive image contrasts for evaluation of the brain tumor microenvironment. Advantages include fast whole-brain acquisition, in-line B0 correction, and simultaneous estimation of CEST effects, R2 , R2*, and R2' at 3 T.
PURPOSE: To introduce a new pH-sensitive and oxygen-sensitive MRI technique using amine proton CEST echo spin-and-gradient echo (SAGE) EPI (CEST-SAGE-EPI). METHODS: pH-weighting was obtained using CEST estimations of magnetization transfer ratio asymmetry (MTRasym ) at 3 ppm, and oxygen-weighting was obtained using R2' measurements. Glutamine concentration, pH, and relaxation rates were varied in phantoms to validate simulations and estimate relaxation rates. The values of MTRasym and R2' in normal-appearing white matter, T2 hyperintensity, contrast enhancement, and macroscopic necrosis were measured in 47 gliomas. RESULTS: Simulation and phantom results confirmed an increase in MTRasym with decreasing pH. The CEST-SAGE-EPI estimates of R2 , R2*, and R2' varied linearly with gadolinium diethylenetriamine penta-acetic acid concentration (R2 = 6.2 mM-1 ·sec-1 and R2* = 6.9 mM-1 ·sec-1 ). The CEST-SAGE-EPI and Carr-Purcell-Meiboom-Gill estimates of R2 (R2 = 0.9943) and multi-echo gradient-echo estimates of R2* (R2 = 0.9727) were highly correlated. T2 lesions had lower R2' and higher MTRasym compared with normal-appearing white matter, suggesting lower hypoxia and high acidity, whereas contrast-enhancement tumor regions had elevated R2' and MTRasym , indicating high hypoxia and acidity. CONCLUSION: The CEST-SAGE-EPI technique provides simultaneous pH-sensitive and oxygen-sensitive image contrasts for evaluation of the brain tumor microenvironment. Advantages include fast whole-brain acquisition, in-line B0 correction, and simultaneous estimation of CEST effects, R2 , R2*, and R2' at 3 T.
Authors: Heiko Schmiedeskamp; Matus Straka; Rexford D Newbould; Greg Zaharchuk; Jalal B Andre; Jean-Marc Olivot; Michael E Moseley; Gregory W Albers; Roland Bammer Journal: Magn Reson Med Date: 2011-11-23 Impact factor: 4.668
Authors: Benjamin S Geisler; Frank Brandhoff; Jens Fiehler; Christian Saager; Oliver Speck; Joachim Röther; Hermann Zeumer; Thomas Kucinski Journal: Stroke Date: 2006-06-01 Impact factor: 7.914
Authors: Hua Guo; Wing-Yan Au; Jerry S Cheung; Daniel Kim; Jens H Jensen; Pek-Lan Khong; Queenie Chan; Kevin C Chan; Christina Tosti; Haiying Tang; Truman R Brown; Wynnie W M Lam; Shau-Yin Ha; Gary M Brittenham; Ed X Wu Journal: J Magn Reson Imaging Date: 2009-08 Impact factor: 4.813
Authors: Jeannette R Flynn; Libo Wang; David L Gillespie; Gregory J Stoddard; Jason K Reid; Jason Owens; Grant B Ellsworth; Karen L Salzman; Anita Y Kinney; Randy L Jensen Journal: Cancer Date: 2008-09-01 Impact factor: 6.860
Authors: Jingwen Yao; Caleb Hock Pang Tan; Jacob Schlossman; Ararat Chakhoyan; Catalina Raymond; Whitney B Pope; Noriko Salamon; Albert Lai; Matthew Ji; Phioanh L Nghiemphu; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson Journal: J Neurooncol Date: 2019-02-26 Impact factor: 4.130
Authors: Y-L Wang; J Yao; A Chakhoyan; C Raymond; N Salamon; L M Liau; P L Nghiemphu; A Lai; W B Pope; N Nguyen; M Ji; T F Cloughesy; B M Ellingson Journal: AJNR Am J Neuroradiol Date: 2019-05-16 Impact factor: 3.825
Authors: Jingwen Yao; Ararat Chakhoyan; David A Nathanson; William H Yong; Noriko Salamon; Catalina Raymond; Sergey Mareninov; Albert Lai; Phioanh L Nghiemphu; Robert M Prins; Whitney B Pope; Richard G Everson; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson Journal: Neuro Oncol Date: 2019-09-06 Impact factor: 12.300
Authors: Tatyana D Larionova; Soniya Bastola; Tatiana E Aksinina; Ksenia S Anufrieva; Jia Wang; Victoria O Shender; Dmitriy E Andreev; Tatiana F Kovalenko; Georgij P Arapidi; Polina V Shnaider; Anastasia N Kazakova; Yaroslav A Latyshev; Victor V Tatarskiy; Alexander A Shtil; Pascale Moreau; Francis Giraud; Chaoxi Li; Yichan Wang; Maria P Rubtsova; Olga A Dontsova; Michael Condro; Benjamin M Ellingson; Mikhail I Shakhparonov; Harley I Kornblum; Ichiro Nakano; Marat S Pavlyukov Journal: Nat Cell Biol Date: 2022-10-03 Impact factor: 28.213
Authors: Benjamin M Ellingson; Davis C Woodworth; Kevin Leu; Noriko Salamon; Langston T Holly Journal: World Neurosurg Date: 2019-05-09 Impact factor: 2.104
Authors: Hamed Akbari; Anahita Fathi Kazerooni; Jeffrey B Ware; Elizabeth Mamourian; Hannah Anderson; Samantha Guiry; Chiharu Sako; Catalina Raymond; Jingwen Yao; Steven Brem; Donald M O'Rourke; Arati S Desai; Stephen J Bagley; Benjamin M Ellingson; Christos Davatzikos; Ali Nabavizadeh Journal: Sci Rep Date: 2021-07-22 Impact factor: 4.379